Skip to main content
. 2023 Jan 16;13:1098357. doi: 10.3389/fonc.2023.1098357

Figure 2.

Figure 2

Pan-cancer patient survival analysis. Overall survival (OS) analysis of MTHFD2 in different tumors using Kaplan–Meier survival curves. (A) ACC, (B) BLCA, (C) BRCA, (D) CESC, (E) CHOL, (F) COAD, (G) ESCA, (H) GBM, (I) HNSC, (J) KIRC, (K) KIRP, (L) LIHC, (M) LUAD, (N) LUSC, (O) OV, (P) PAAD, (Q) SARC, (R) STAD, (S) THCA, (T) UCEC. Red lines indicate high MTHFD2 expression, while blue lines indicate low MTHFD2 expression.